Alnylam Pharmaceuticals, Inc. (LON:0HD2)
London flag London · Delayed Price · Currency is GBP · Price in USD
452.83
+0.93 (0.21%)
At close: Aug 28, 2025

Alnylam Pharmaceuticals Market Cap

Alnylam Pharmaceuticals has a market cap or net worth of 44.20 billion as of August 28, 2025. Its market cap has increased by 62.88% in one year.

Market Cap
44.20B
Enterprise Value
44.11B
Revenue
1.80B
Ranking
n/a
PE Ratio
n/a
Stock Price
452.83

Market Cap Chart

Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 63.23M to 44.20B, an increase of 69,800.72%. That is a compound annual growth rate of 36.07%.

History

DateMarket Cap% Change
Aug 27, 202544.20B82.30%
Dec 31, 202424.24B28.56%
Dec 29, 202318.86B-22.29%
Dec 30, 202224.27B62.00%
Dec 31, 202114.98B35.43%
Dec 31, 202011.06B14.08%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition